Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (131-140 of 539) with videos related to

Pageof 54
Sort By:
Annals of Hematology|May 18, 2013
Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseasesRajiv Shah, Bram Stieltjes, Mindaugas Andrulis, et al.
BMC Cancer|August 17, 2018
Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patientsSeyed Hamidreza Mahmoudpour, Obul Reddy Bandapalli, Miguel Inácio da Silva Filho, et al.
Oncotarget|December 13, 2017
<i>CD24</i>, <i>CD27</i>, <i>CD36</i> and <i>CD302</i> gene expression for outcome prediction in patients with multiple myelomaElina Alaterre, Sebastien Raimbault, Hartmut Goldschmidt, et al.
European Journal of Haematology|September 20, 2023
A precision-based exercise program for patients with multiple myelomaUlrike Dapunt, Pauline Ehret, Jean-Luc Paratte, et al.
BMC Cancer|May 15, 2010
Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarraysKarène Mahtouk, Jérôme Moreaux, Dirk Hose, et al.
Hematological Oncology|March 19, 2015
Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow functionIris Breitkreutz, Natalia Becker, Axel Benner, et al.
BMJ Open|August 1, 2018
Association of resilience with health-related quality of life and depression in multiple myeloma and its precursors: results of a German cross-sectional studyImad Maatouk, Susanne He, Natalia Becker, et al.
Cancers|November 14, 2023
Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation-Results from the LenaMain Trial (NCT00891384)Amelie Boquoi, Aristoteles Giagounidis, Hartmut Goldschmidt, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 23, 2005
Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markersSílvia Nosàs-Garcia, Thomas Moehler, Klaus Wasser, et al.
Hematological Oncology|February 16, 2018
Carfilzomib in relapsed or refractory multiple myeloma patients with early or late relapse following prior therapy: A subgroup analysis of the randomized phase 3 ASPIRE and ENDEAVOR trialsMaria-Victoria Mateos, Hartmut Goldschmidt, Jesus San-Miguel, et al.
Pageof 54

Showing results (131-140 of 539) with videos related to

Sort By:
Pageof 54
Annals of Hematology|May 18, 2013
Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseasesRajiv Shah, Bram Stieltjes, Mindaugas Andrulis, et al.
BMC Cancer|August 17, 2018
Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patientsSeyed Hamidreza Mahmoudpour, Obul Reddy Bandapalli, Miguel Inácio da Silva Filho, et al.
Oncotarget|December 13, 2017
<i>CD24</i>, <i>CD27</i>, <i>CD36</i> and <i>CD302</i> gene expression for outcome prediction in patients with multiple myelomaElina Alaterre, Sebastien Raimbault, Hartmut Goldschmidt, et al.
European Journal of Haematology|September 20, 2023
A precision-based exercise program for patients with multiple myelomaUlrike Dapunt, Pauline Ehret, Jean-Luc Paratte, et al.
BMC Cancer|May 15, 2010
Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarraysKarène Mahtouk, Jérôme Moreaux, Dirk Hose, et al.
Hematological Oncology|March 19, 2015
Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow functionIris Breitkreutz, Natalia Becker, Axel Benner, et al.
BMJ Open|August 1, 2018
Association of resilience with health-related quality of life and depression in multiple myeloma and its precursors: results of a German cross-sectional studyImad Maatouk, Susanne He, Natalia Becker, et al.
Cancers|November 14, 2023
Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation-Results from the LenaMain Trial (NCT00891384)Amelie Boquoi, Aristoteles Giagounidis, Hartmut Goldschmidt, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 23, 2005
Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markersSílvia Nosàs-Garcia, Thomas Moehler, Klaus Wasser, et al.
Hematological Oncology|February 16, 2018
Carfilzomib in relapsed or refractory multiple myeloma patients with early or late relapse following prior therapy: A subgroup analysis of the randomized phase 3 ASPIRE and ENDEAVOR trialsMaria-Victoria Mateos, Hartmut Goldschmidt, Jesus San-Miguel, et al.
Pageof 54